CellChorus

Laboratory Equipment · Artificial Intelligence

Overview

CellChorus conducts dynamic single-cell analysis at scale. Time-lapse Imaging Microscopy in Nanowell Grids (TIMING) uses visual AI to evaluate how cells behave in a variety of environmental conditions.

Funding and backers

Grants
$5.8M
8 grants · CORDIS
Backers
2
Y Combinator, BioTools Innovator
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 1, 2025 Won a grant $400k · CORDIS Aug 1, 2025 Won a grant $1.1M · CORDIS May 1, 2025 Won a grant $984k · CORDIS Aug 8, 2024 Won a grant $349k · CORDIS Aug 1, 2024 Won a grant $2M · CORDIS May 1, 2024 Won a grant $350k · CORDIS Jun 1, 2023 Won a grant $275k · CORDIS May 1, 2023 Won a grant $324k · CORDIS Jun 2021 Went through Y Combinator Aug 2018 Website went live first capture in the Wayback Machine
Tractionpublic signals, read monthly
Web presence
top 8%
of 133.2M domains by links, Common Crawl
Funding rounds
RoundDateAmountInvestorsSource
Grant Sep 2025 $400k — CORDIS
Grant Aug 2025 $1.1M — CORDIS
Grant May 2025 $984k — CORDIS
Grant Aug 2024 $349k — CORDIS
Grant Aug 2024 $2M — CORDIS
Grant May 2024 $350k — CORDIS
Grant Jun 2023 $275k — CORDIS
Grant May 2023 $324k — CORDIS
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Atrandi BiosciencesSeries A $25M · 20 mo ago · Founded 2016 · 51-200 employees · 2 roles
Advanced single-cell solutions by Atrandi. Discover high-throughput single-cell technologies for genomics, screening, and biological…
IVIM TechnologyFounded 2017
The world’s first All-in-One intravital microscopy platform from IVIM Technology is a key solution that can explore complex dynamic…
Ramona Optics, Inc.Series A $26M · 8 mo ago · Founded 2018 · 51-200 employees
Ramona builds the world's fastest live-cell and small-organism imaging systems. Image a full 96-well plate in under 2 minutes with…
ThinkCyteSeries C $32M · 2 yr ago · 201-500 employees
ThinkCyte develops single-cell analysis technologies that combine advanced optics, machine learning and biotechnology to support…
ONI201-500 employees · 13 roles
ONI offers innovative super-resolution microscopy systems including Aplo Scope, Nanoimager, and Aplo Flow. Explore dSTORM, PALM, DNA-PAINT…
Owlo11-50 employees
Owlo is a deep-tech company developing the next generation of non-invasive microscopy for healthcare.

Visa sponsorship

#3,445 of 8,998 sponsors
3
H-1B filings in 12 months
$113k
Median offered salary
0
Open roles in United States
Who they sponsor
Other biological scientists
3
The salary offered for each occupationVisa pass · 90 credits
In the register as CellChorus Inc, Houston, TX
Other sponsors in the same field
Alert me
US Department of Labor · latest filing Apr 28, 2026 · Visa details by country

Financials

Total raised
$5.8M
Latest round
Grant
Funding rounds
8
Funding rounds
Round Announced Amount
Grant 2025 $400k Details
Grant 2025 $1.1M Details
Grant 2025 $984k Details
Grant 2024 $349k Details
Grant 2024 $2M Details
Grant 2024 $350k Details
Grant 2023 $275k Details
Grant 2023 $324k Details

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors2
39 portfolio companies: EpiPaws</a> (Copy), Eukarys, Innovator and 36 more
Y CombinatorVia a fund
6310 portfolio companies

News

News NatImmunol 9 years ago
IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functions
Monoclonal antibody (mAb) therapy is now commonplace in the clinic, yet such reagents can elicit unwanted side effects due to interactions with Fcγ receptors. Georgiou and colleagues have engineered mAbs that lack such FcγR interactions but retain the abi
Read more
Report
News NatImmunol 9 years ago
IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functions
Monoclonal antibody (mAb) therapy is now commonplace in the clinic, yet such reagents can elicit unwanted side effects due to interactions with Fcγ receptors. Georgiou and colleagues have engineered mAbs that lack such FcγR interactions but retain the abi
Read more
Report

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Houston United States
HQ
5000 Gulf Freeway Houston, TX 77023 United States
company site